4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0000950170-25-084556
Chief Operating Officer sold 25,000 shares at $110.44 ($2,761,000)
- Chief Operating Officer acquired 25,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jacobson Mark L. Chief Operating Officer | 2025-06-09 | Option exercise 10b5-1 | +25,000 | $8.02 | $200,500 | 30,783 | D |
| Jacobson Mark L. Chief Operating Officer | 2025-06-09 | Sale 10b5-1 | −25,000 | $110.44 | $2,761,000 | 5,783 | D |
| Derivatives | |||||||
| Jacobson Mark L. Chief Operating Officer | 2025-06-09 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −25,000 | 0 | D | ||
| Open-market sales · 25,000 sh · avg $110.44 · $2,761,000 | |||||||
Loading xslF345X05/ownership.xml…